Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6
Yoon Min, Sae Mi Wi, Jung‐Ah Kang, et al.
Cell Death and Disease (2016) Vol. 7, Iss. 7, pp. e2313-e2313
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation
Yoon Min, Mi‐Jeong Kim, Sena Lee, et al.
Autophagy (2018) Vol. 14, Iss. 8, pp. 1347-1358
Open Access | Times Cited: 174
Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
Yoo Jin Jung, David Tweedie, Michael T. Scerba, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 114
Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis
Chao Li, Runchen Miao, Sushun Liu, et al.
Oncotarget (2017) Vol. 8, Iss. 17, pp. 28683-28695
Open Access | Times Cited: 105
USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction
Mi‐Jeong Kim, Yoon Min, Soo‐Kyung Jeong, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 39
A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders
David Millrine, Tadamitsu Kishimoto
Trends in Molecular Medicine (2017) Vol. 23, Iss. 4, pp. 348-361
Open Access | Times Cited: 77
Circ_0114428 Regulates Sepsis-Induced Kidney Injury by Targeting the miR-495-3p/CRBN Axis
Yan He, Yuanzhu Sun, Jun Peng
Inflammation (2021) Vol. 44, Iss. 4, pp. 1464-1477
Closed Access | Times Cited: 46
FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB
Mi‐Jeong Kim, Do Young ‍Kim, Ji Hye Shin, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies
Ian F. Caplan, Kathleen A. Maguire‐Zeiss
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 54
Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation
Qinglin Shi, Lijuan Chen
Journal of Immunology Research (2017) Vol. 2017, pp. 1-8
Open Access | Times Cited: 51
Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation
Eleftheria Papaioannou, Diana C. Yánez, Susan Ross, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3153-3170
Open Access | Times Cited: 51
Neurodevelopmental Disorders (NDD) Caused by Genomic Alterations of the Ubiquitin-Proteasome System (UPS): the Possible Contribution of Immune Dysregulation to Disease Pathogenesis
Frédéric Ebstein, Sébastien Küry, Jonas Johannes Papendorf, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 38
β‐arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4
Do Young ‍Kim, Ji Hye Shin, Mi‐Jeong Kim, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 15
Ubiquitin-Specific Protease 14 Negatively Regulates Toll-Like Receptor 4-Mediated Signaling and Autophagy Induction by Inhibiting Ubiquitination of TAK1-Binding Protein 2 and Beclin 1
Yoon Min, Sena Lee, Mi‐Jeong Kim, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 43
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
Afua A. Akuffo, Aileen Y. Alontaga, Rainer Metcalf, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 16, pp. 6187-6200
Open Access | Times Cited: 41
Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun
H. J. Yang, Min Huang, Liang Zhou, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 26, pp. 10141-10157
Open Access | Times Cited: 40
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury
Daniela Lecca, Shih‐Chang Hsueh, Weiming Luo, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 11
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders
Katherine O. Kopp, Margaret E. Greer, Elliot J. Glotfelty, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 747-747
Open Access | Times Cited: 11
p62 is Negatively Implicated in the TRAF6-BECN1 Signaling Axis for Autophagy Activation and Cancer Progression by Toll-Like Receptor 4 (TLR4)
Mi‐Jeong Kim, Yoon Min, Ji Seon Im, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1142-1142
Open Access | Times Cited: 31
Influence of Cytokine-Related genetic variants in TNF, IL6, IL1β, and IFNγ genes in the thalidomide treatment for Erythema nodosum leprosum in a Brazilian population sample
Miriãn Ferrão Maciel-Fiuza, Renan César Sbruzzi, Mariléa Furtado Feira, et al.
Human Immunology (2025) Vol. 86, Iss. 2, pp. 111260-111260
Closed Access
3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat
Kai‐Yun Chen, Shih‐Chang Hsueh, Pathik Parekh, et al.
GeroScience (2025)
Open Access
CRBN Is a Negative Regulator of Bactericidal Activity and Autophagy Activation Through Inhibiting the Ubiquitination of ECSIT and BECN1
Mi‐Jeong Kim, Yoon Min, Jae‐Hyuck Shim, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 23
AMPKα1 Regulates Lung and Breast Cancer Progression by Regulating TLR4-Mediated TRAF6-BECN1 Signaling Axis
Mi‐Jeong Kim, Yoon Min, Juhee Son, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3289-3289
Open Access | Times Cited: 21
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs
Ota Fuchs
Cardiovascular & Haematological Disorders - Drug Targets (2018) Vol. 19, Iss. 1, pp. 51-78
Closed Access | Times Cited: 22
Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma Therapy
Matteo Costacurta, Jackson He, Philip E. Thompson, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1185-1185
Open Access | Times Cited: 17
Thalidomide Attenuates Mast Cell Activation by Upregulating SHP-1 Signaling and Interfering with the Action of CRBN
Hyeun‐Wook Chang, Kyeong-Hwa Sim, Younju Lee
Cells (2023) Vol. 12, Iss. 3, pp. 469-469
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top